Keefe, Bruyette & Woods Upgrades Unum Gr to Outperform, Raises Price Target to $52
Keefe, Bruyette & Woods analyst Ryan Krueger upgrades Unum Gr (NYSE:UNM) from Market Perform to Outperform and raises the price target from $49 to $52.
JP Morgan Upgrades MPLX to Overweight, Raises Price Target to $41
JP Morgan analyst Jeremy Tonet upgrades MPLX (NYSE:MPLX) from Neutral to Overweight and raises the price target from $37 to $41.
Barclays Upgrades Match Group to Overweight, Announces $52 Price Target
Barclays analyst Mario Lu upgrades Match Group (NASDAQ:MTCH) from Equal-Weight to Overweight and announces $52 price target.
Wolfe Research Upgrades Tricon Residential to Outperform
Wolfe Research analyst Keegan Carl upgrades Tricon Residential (NYSE:TCN) from Peer Perform to Outperform.
Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target
Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.
Alembic Global Upgrades Methanex to Overweight, Announces $60 Price Target
Alembic Global analyst Hassan Ahmed upgrades Methanex (NASDAQ:MEOH) from Neutral to Overweight and announces $60 price target.
DA Davidson Upgrades Joint to Neutral, Raises Price Target to $15
DA Davidson analyst Linda Bolton Weiser upgrades Joint (NASDAQ:JYNT) from Underperform to Neutral and raises the price target from $12 to $15.
Baird Upgrades Truist Finl to Outperform, Announces $53 Price Target
Baird analyst David George upgrades Truist Finl (NYSE:TFC) from Neutral to Outperform and announces $53 price target.
TD Cowen Upgrades Moderna to Outperform, Raises Price Target to $180
TD Cowen analyst Tyler Van Buren upgrades Moderna (NASDAQ:MRNA) from Market Perform to Outperform and raises the price target from $150 to $180.
Citigroup Upgrades Charles Schwab to Buy, Lowers Price Target to $75
Citigroup analyst Chris Allen upgrades Charles Schwab (NYSE:SCHW) from Neutral to Buy and lowers the price target from $83 to $75.